ITCMDBv1
Clinical TrialID 5443

Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD

NCT00629044

Glaucoma

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
5443
Evidence Id
5443
Core Evidence Id
5443
Source Clinical Trial Id
5429
Herb2 Clinical Trial Id
HBCT005429
Nct Id
NCT00629044
Title
Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD
Status
Completed
Phase
Study Result
No
Study Condition
Glaucoma
Study Type
Interventional
Study Design
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING
Intervention
BIOLOGICAL: Assessing the blood level of cholesterol 24 S Hydroxylase|BIOLOGICAL: Assessing the blood level of cholesterol 24 S hydroxylase|BIOLOGICAL: assessing the blood level of cholesterol 24 S hydroxylase
Intervention Allocation
Non_Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Screening
Gender
All
Age
Adult, Older_Adult
Enrollment
320
Outcome Measure
To know if cholesterol 24 S hydroxylase and 24 hydroxycholesterol are involve in Glaucoma and AMD, 2 years
Sponsor Collaborator
Centre Hospitalier Universitaire Dijon
Funded By
OTHER
Location
Ophthalmology Unit CHU Dijon, Dijon, Burgundy, 21000, France
Other Id
PHRC IR 2006
Start Date
2007-11
Primary Completion Date
2009-11
Completion Date
2011-01
First Posted
2008-03-05
Results First Posted
Last Update Posted
2011-03-28
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00629044
Title Cn
Title En
Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD
Bilingual Status
semi_complete